BNIP3 as an atypical representative of the Bcl-2 protein family. Part 2: Regulation of the expression and activity of BNIP3 protein and its role in tumorigenesis

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue

Abstract

BNIP3 belongs to the Bcl-2 protein family that regulates programmed cell death. It is the only known pro-apoptotic protein expressed during hypoxia and this effect is determined by the HIF-1 responsive element in the bnip3 promoter. However, there is evidence that hypoxia is not a sufficient factor to activate BNIP3; possible cell death dependent on this protein occurs as a result of secondary effects of oxygen deprivation, such as acidosis. BNIP3 expression is also regulated by other factors, such as E2F-1, NF-κB, and Rb during hypoxia and nitrogen oxide during normoxia. Posttranslational modifications also seem to be essential for BNIP3 activity, but their actual significance is still unclear. Phosphorylation of BNIP3 by PKC promotes its accumulation under hypoxic conditions, but phosphorylation by CK2 can accelerate its degradation. In turn, glycosylation and interactions with anti-apoptotic Bcl-2 proteins suppress BNIP3 activity. Our knowledge about the role of BNIP3 protein in tumor progression is incomplete. It seems to be dependent on the stage of tumor progression. Tumor cells evolved multiple mechanisms of silencing BNIP3 expression or activity and promoter methylation is one of the most frequently observed among them

Authors and Affiliations

Ewelina Swoboda, Leon Strządała

Keywords

Related Articles

Genetyczne uwarunkowania zaburzonej ekspresji termogeniny (UCP1) w otyłości prowadzącej do zespołu metabolicznego

Wzajemne powiązanie zespołu metabolicznego z chorobami układu sercowo-naczyniowego określa się mianem zespołu kardiometabolicznego. W Europie zachorowalność oraz śmiertelność spowodowana chorobami układu krążenia jest na...

Synthetic lethality as a functional tool in basic research and in anticancer therapy

Nowadays, cancer and anticancer therapy are increasingly mentioned topics. Groups of researchers keep looking for a tool that will specifically and efficiently eliminate abnormal cells without any harm for the normal one...

Download PDF file
  • EP ID EP66372
  • DOI -
  • Views 129
  • Downloads 0

How To Cite

Ewelina Swoboda, Leon Strządała (2009). BNIP3 as an atypical representative of the Bcl-2 protein family. Part 2: Regulation of the expression and activity of BNIP3 protein and its role in tumorigenesis. Advances in Hygiene and Experimental Medicine, 63(), 418-424. https://europub.co.uk/articles/-A-66372